首页> 美国卫生研究院文献>Mdica >Cholesterol and Phospholipid Distribution Pattern in the Erythrocyte Membrane of Patients with Hepatitis C and Severe Fibrosis before and after Treatment with Direct Antiviral Agents: A pilot Study

【2h】

Cholesterol and Phospholipid Distribution Pattern in the Erythrocyte Membrane of Patients with Hepatitis C and Severe Fibrosis before and after Treatment with Direct Antiviral Agents: A pilot Study

机译：用直接抗病毒剂治疗前后抗纤维化患者红细胞膜的胆固醇和磷脂分布模式治疗前后抗病毒剂：试验研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives: Hepatitis C virus requires and induces changes in liver lipidome for its life cycle. In addition, alterations in plasma and erythrocyte lipidome are observed during a range of chronic liver diseases.

机译：目的：丙型肝炎病毒需要并诱导肝脏脂质组的变化为生命周期。此外，在一系列慢性肝疾病期间观察到血浆和红细胞脂质体的改变。

著录项

期刊名称 Mdica
作者
Charalampos PAPADOPOULOS; Maria PANOPOULOU; Theodora MYLOPOULOU; Konstantinos MIMIDIS; Ioannis TENTES; Konstantinos ANAGNOSTOPOULOS;
展开▼
作者单位

展开▼
年(卷),期 2020(15),2
年度 2020
页码 162–168
总页数 7
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis [J] . Petta Salvatore, Adinolfi Luigi Elio, Fracanzani Anna Ludovica, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2018,第1期

机译：通过直接作用抗病毒药物消除丙型肝炎病毒改善了严重肝纤维化患者的颈动脉粥样硬化
2. Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents [J] . Wei-Fan Hsu, Hsueh-Chou Lai, Wen-Pang Su, BMC Gastroenterology . 2019,第1期

机译：接受直接作用抗病毒药治疗的丙型肝炎患者非侵入性纤维化指标值迅速下降
3. Evolution of thrombocytopenia in patients with hepatitis C virus infection and advanced fibrosis after treatment with direct antiviral agents. [J] . Gomez-Camarero Judith, Linares Pedro, Martin Maria I., Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：直接抗病毒治疗后丙型肝炎病毒感染患者血小板减少症患者的演变。
4. Incorporation of a DIRECT ACTING ANTIVIRAL Treatment for HEPATITIS C in the Brazilian Public Health System [C] . Mayra Braga Lemos, Milene Rangel da Costa, Rosimary Terezinha de Almeida Brazilian Congress on Biomedical Engineering . 2019

机译：加入巴西公共卫生系统丙型肝炎直接作用抗病毒治疗
5. The Distribution of Change over Time in Metabolic, Inflammatory, and Immune Parameters in HCV-monoinfected and HIV/HCV-coinfected Patients Cured of Hepatitis C Virus by Direct-Acting Antiviral Therapy [D] . Emmanuel, Benjamin. 2018

机译：通过直接作用抗病毒治疗，在HCV-单染料和HCV / HCV / HCV-焦收的患者中的代谢，炎症和免疫参数随时间随时间的分布，通过直接作用抗病毒治疗治愈丙型肝炎病毒
6. Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents [O] . Wei-Fan Hsu, Hsueh-Chou Lai, Wen-Pang Su, 2019

机译：接受直接作用抗病毒药治疗的丙型肝炎患者非侵入性纤维化指标值迅速下降
7. Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents [O] . C Hamoir, Y Horsmans, P Stärkel, 2021

机译：用直接作用抗病毒药治疗肝炎患者肝细胞癌患者肝细胞癌和纤维化进化的风险

Cholesterol and Phospholipid Distribution Pattern in the Erythrocyte Membrane of Patients with Hepatitis C and Severe Fibrosis before and after Treatment with Direct Antiviral Agents: A pilot Study

摘要

著录项

相似文献

相关主题

期刊订阅